The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer

被引:4
|
作者
Aristei, C. [1 ,2 ]
Kaidar-Person, O. [3 ]
Boersma, L. [4 ]
Leonardi, M. C. [5 ]
Offersen, B. [6 ]
Franco, P. [7 ,8 ]
Arenas, M. [9 ]
Bourgier, C. [10 ]
Pfeffer, R. [11 ]
Kouloulias, V [12 ]
Bolukbasi, Y. [13 ]
Meattini, I [14 ,15 ]
Coles, C. [16 ]
Luis, A. Montero [17 ]
Masiello, V. [18 ]
Palumbo, I. [1 ,2 ]
Morganti, A. G. [19 ,20 ]
Perrucci, E. [21 ]
Tombolini, V. [22 ]
Krengli, M. [23 ,24 ]
Marazzio, F. [25 ]
Trigo, L.
Borghesi, S. [26 ]
Ciabattoni, A. [27 ]
Ratosa, I. [28 ,29 ]
Valentini, V. [30 ,31 ]
Poortmans, P. [32 ,33 ]
机构
[1] Univ Perugia, Radiat Oncol Sect, Dept Med & Surg, I-06156 Perugia, Italy
[2] Perugia Gen Hosp, I-06156 Perugia, Italy
[3] Sheba Med Ctr, Breast Radiat Unit, Radiat Oncol, Ramat Gan, Israel
[4] Maastricht Univ, GROW Sch Oncol & Dev Biol, Med Ctr, Radiat Oncol Maastro, Maastricht, Netherlands
[5] IRCCS, IEO European Inst Oncol, Div Radiat Oncol, Milan, Italy
[6] Aarhus Univ Hosp, Danish Ctr Particle Therapy, Dept Expt Clin Oncol, Dept Oncol, Aarhus, Denmark
[7] Univ Piemonte Orientale, Depatment Translat Med, Novara, Italy
[8] Maggiore Carita Univ Hosp, Dept Radiat Oncol, Novara, Italy
[9] Univ Rovira I Virgili, Hosp Universitari St Hoan Reus, IISPV, Radiat Oncol Dept, Tarragona, Spain
[10] Univ Montpellier, ICM Val Aurelle, Radiat Oncol, Montpellier, France
[11] Tel Aviv & Ben Gur Univ, Oncol Inst, Med Sch, Assuta Med Ctr, Beer Sheva, Israel
[12] Natl & Kapodistrian Univ Athens, Med Sch, Dept Radiol 2, Radiotherapy Unit, Zografos, Greece
[13] Koc Univ, Fac Med, Dept Radiat Oncol, Istanbul, Turkiye
[14] Univ Florence, Dept Expt & Clin Biomed Sci M Serio, Thales, Italy
[15] Azienda Ospedaliero Univ Careggi, Oncol Dept, Radiat Oncol Unit, Florence, Italy
[16] Univ Cambridge, Dept Oncol, Cambridge, England
[17] Hosp Univ HM Sanchinarro, HM Hosp, Dept Radiat Oncol, Madrid, Spain
[18] Fdn Policlin Gemelli IRCSS Roma, Dipartimento Diagnost Immagini, Unita Operativa Radioterapia Oncolog, Radioterapia Oncolog Ematol, Rome, Italy
[19] Alma Mater Studiorum Univ Bologna, DIMES, Bologna, Italy
[20] Alma Mater Studiorum Bologna Univ, IRCCS Azienda Ospedaliero Univ Bologna, Radiat Oncol, Bologna, Italy
[21] Perugia Gen Hosp, Radiat Oncol Sect, Perugia, Italy
[22] Univ Roma La Sapienza, Dept Radiol Oncol & Pathol Sci, Radiat Oncol, Rome, Italy
[23] Univ Padua, Padua, Italy
[24] Ist Oncol Veneto IRCCS, Padua, Italy
[25] Inst Portugues Oncol Porto Francisco Gentil EPE, Dept Image & Radioncol, Serv Brachytherapy, Porto, Portugal
[26] Azienda USL Toscana Sud Est, Radiat Oncol Unit Arezzo Valdarno, Arezzo, Italy
[27] San Filippo Neri Hosp, Clin & Rehabil Cardiol Unit, ASL Rome 1, Rome, Italy
[28] Inst Oncol Ljubljana, Div Radiat Oncol, Ljubljana, Slovenia
[29] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[30] Univ Cattolica Sacro Cuore, Dipartimento Diagnost Immagini, Radioterapia Oncol & Ematol, Milan, Iran
[31] Fdn Policlin Gemelli IRCSS Roma, Rome, Iran
[32] Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium
[33] Fac Med & Hlth Sci, Iridium Kankernetwerk, Dept Radiat Oncol, Antwerp, Belgium
关键词
Breast cancer; Radiation therapy; Combined modality treatment; Immunotherapy; Re-irradiation in relapsed patients; 2ND CONSERVATIVE TREATMENT; TARGET VOLUME DELINEATION; PEMBROLIZUMAB PLUS CHEMOTHERAPY; ESTRO CONSENSUS GUIDELINE; NEOADJUVANT CHEMOTHERAPY; SURVIVAL OUTCOMES; INTERNAL MAMMARY; SENTINEL NODE; TUMOR EVENT; OPEN-LABEL;
D O I
10.1016/j.critrevonc.2023.104035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present white paper, referring to the 4th Assisi Think Tank Meeting on breast cancer, reviews state-of-the-art data, on-going studies and research proposals. <70% agreement in an online questionnaire identified the following clinical challenges: 1: Nodal RT in patients who have a) 1-2 positive sentinel nodes without ALND (axillary lymph node dissection); b) cN1 disease transformed into ypN0 by primary systemic therapy and c) 1-3 positive nodes after mastectomy and ALND. 2. The optimal combination of RT and immunotherapy (IT), patient selection, IT-RT timing, and RT optimal dose, fractionation and target volume. Most experts agreed that RT-IT combination does not enhance toxicity. 3: Re-irradiation for local relapse converged on the use of partial breast irradiation after second breast conserving surgery. Hyperthermia aroused support but is not widely available. Further studies are required to finetune best practice, especially given the increasing use of re-irradiation.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Radiation Therapy in the Management of Breast Cancer
    Yang, T. Jonathan
    Ho, Alice Y.
    SURGICAL CLINICS OF NORTH AMERICA, 2013, 93 (02) : 455 - +
  • [22] Breast cancer radiation therapy: A bibliometric analysis of the scientific literature
    Franco, Pierfrancesco
    De Felice, Francesca
    Jagsi, Reshma
    Marta, Gustavo Nader
    Kaidar-Person, Orit
    Gabrys, Dorota
    Kim, Kyubo
    Ramiah, Duvern
    Meattini, Icro
    Poortmans, Philip
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 39
  • [23] Risk of Hypothyroidism in Women After Radiation Therapy for Breast Cancer
    Choi, Seo Hee
    Chang, Jee Suk
    Byun, Hwa Kyung
    Son, Nak-Hoon
    Hong, Chae-Seon
    Hong, Namki
    Park, Ye-In
    Kim, Jihun
    Kim, Jin Sung
    Kim, Yong Bae
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (02): : 462 - 472
  • [24] The roles and controversies of radiation therapy in breast conserving therapy for breast cancer
    Hiraoka M.
    Mitsumori M.
    Kokubo M.
    Breast Cancer, 1997, 4 (3) : 127 - 133
  • [25] Radiation therapy and immunotherapy in breast cancer treatment: preliminary data and perspectives
    Cao, Kim
    Abbassi, Louisa
    Romano, Emanuela
    Kirova, Youlia
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (05) : 501 - 509
  • [26] Radiation-related heart disease after breast cancer radiation therapy in Korean women
    Chang, Jee Suk
    Ko, Byung Kyun
    Bae, Jeoung Won
    Yu, Jong-Han
    Park, Min Ho
    Jung, Yongsik
    Jeon, Ye Won
    Kim, Kyung Hwan
    Shin, Jaeyong
    Suh, Chang-Ok
    Kim, Yong Bae
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 249 - 257
  • [27] The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition
    Michio Yoshimura
    Chikako Yamauchi
    Naoko Sanuki
    Yasushi Hamamoto
    Kimiko Hirata
    Jiro Kawamori
    Mariko Kawamura
    Mami Ogita
    Yutaka Yamamoto
    Hiroji Iwata
    Shigehira Saji
    Breast Cancer, 2024, 31 : 347 - 357
  • [28] The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition
    Yoshimura, Michio
    Yamauchi, Chikako
    Sanuki, Naoko
    Hamamoto, Yasushi
    Hirata, Kimiko
    Kawamori, Jiro
    Kawamura, Mariko
    Ogita, Mami
    Yamamoto, Yutaka
    Iwata, Hiroji
    Saji, Shigehira
    BREAST CANCER, 2024, 31 (03) : 347 - 357
  • [29] This house believes that all node positive breast cancer patients need post mastectomy radiation therapy
    Offersen, Birgitte Vrou
    Poortmans, Philip
    EJSO, 2021, 47 (10): : 2521 - 2524
  • [30] Feasibility of Breast Radiation Therapy Video Education Combined With Standard Radiation Therapy Education for Patients With Breast Cancer
    Pembroke, Michelle
    Bradley, Julie
    Mueller, Martina
    Mollica, Michelle
    Nemeth, Lynne S.
    ONCOLOGY NURSING FORUM, 2021, 48 (03) : 279 - 290